Fardales RR, Rodríguez RMA, Castellanos GLA

Language: Spanish
References: 6
Page: 1-2
PDF size: 102.13 Kb.

Text Extraction

No abstract.

REFERENCES

1. Joachim Alexandre, MD, PhD*; Jennifer Cautela, MD*; Stéphane Ederhy, MD; Ghandi Laurent Damaj, MD, PhD. Joe-Elie Salem , MD, PhD; Fabrice Barlesi, MD Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio-Oncology Guidelines. J Am Heart Assoc.2020;9:e018403. DOI: 10.1161/JAHA.120.018403.

2. Prohias Martínez JA, Luperon Loforte D, López Gutierrez A, Claro Valdés R. Servicio de Cardiooncología en un Hospital Terciario: Experiencia del Hospital Hermanos Ameijeiras.Rev Cub Card. Volumen 26, No 3 (2020). Jul-Sep. ISSN: 1561-2937.

3. S. Anker M, Hadzibegovic S, Lena A, Belenkov Y, Bergler-Klein J, de Boer RA, Farmakis D, von Haehling S et al. Recent advances in cardio-oncology: a report from the ‘Heart Failure Association2019and World Congress on Acute Heart Failure2019’.ESC Heart Failure. Published online in Wiley Online Library (wileyonlinelibrary.com)DOI:10.1002/ehf2.12551.

4. López-Fernández T, Martín García A,Santaballa Beltrán A, Montero Luis Á, García Sanz R, Mazón Ramos P et all. Cardio-onco-hematology in clinical practice. Position paper and recommendations.Rev Esp Cardiol (Engl Ed)2017;70:474–486.

5. Rodríguez-Ramos MA, Fardales-Rodríguez R. Managing cardiotoxicity induced by chemotherapy in centers from low income countries. Review * Prehľadový článo. 2019;28(1):21–25.

6. Herrmann J, Lerman A, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M. Evaluation and management of patients with heart disease and cancer: Cardio-Oncology. Mayo Clin Proc. 2014;89(9): 1287-306.